Salute e Benessere
DRG Is Launching Innovative Traumatic Brain Injury (TBI) Test Panel at MEDLAB in Dubai
DRG's TBI Tests are CE-marked and have been verified to meet CLSI (Clinical and Laboratory Standards Institute) requirements. They are intended for use in a clinical laboratory setting and are indicated for patients aged 18 years or older.
To learn more about the test availability in your region or for more information about DRG's TBI Tests, please contact our Sales Representative or email
DRG will also showcase the TBI tests at the upcoming , which will take place at the Dubai World Trade Centre from
. The Product Development Team will be on hand to answer any questions about the TBI tests.
DRG Instruments GmbH, was established in 1973 and is based in Marburg. Since 1990, DRG Instruments has developed and manufactured innovative immunoassays, both for routine and research applications, with distribution partners in over 120 countries. DRG is also the manufacturer of the DRG:HYBRiD-XL , a fully automated analyzer for immunoassays and clinical chemistry. DRG is an ISO 13485-certified company and operates in accordance with the FDA 21 CFR 820 Quality System Regulation. To learn more, visit https://www.drg-diagnostics.de/ , or follow us on LinkedIn ,
Logo - https://mma.prnewswire.com/media/2610169/DRG_NEUROSCIENCE_CMYK_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/drg-is-launching-innovative-traumatic-brain-injury-tbi-test-panel-at-medlab-in-dubai-302365100.html